Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Hemophilia Gene Therapy Patient Journey: Questions and Answers for Shared Decision-Making
Michael Wang, Claude Négrier, Frank Drießler, et al.
Patient Preference and Adherence (2022) Vol. Volume 16, pp. 1439-1447
Open Access | Times Cited: 25

Showing 25 citing articles:

Liver-related aspects of gene therapy for hemophilia: need for collaborations with hepatologists
Wolfgang Miesbach, Graham R. Foster, Flora Peyvandi
Journal of Thrombosis and Haemostasis (2023) Vol. 21, Iss. 2, pp. 200-203
Open Access | Times Cited: 17
Barriers to gene therapy, understanding the concerns people with haemophilia have: an exigency sub-study
Simon Fletcher, Kathryn Jenner, Michael Holland, et al.
Orphanet Journal of Rare Diseases (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 5
The benefits of gene therapy in people with haemophilia
Courtney D. Thornburg
Journal of Viral Hepatitis (2024) Vol. 31, Iss. S1, pp. 4-8
Open Access | Times Cited: 4
Operationalising a Haemophilia Gene Editing Lexicon for Practical Use
William McKeown, Cédric Hermans, Carmen Unzu, et al.
Haemophilia (2025)
Closed Access
“I’d go on a hike with my kids… that would make me feel so happy.” Recognising what people with haemophilia B identify as meaningful when considering personal goals and the potential for gene therapy
Kate Khair, Ranjit Nagra, Richard Gorman, et al.
The Journal of Haemophilia Practice (2025) Vol. 12, Iss. 1, pp. 1-14
Open Access
The emerging need to manage patient expectations of haemophilia gene therapy amidst media hype in the UK
Laurence Woollard, Richard Gorman
Therapeutic Advances in Rare Disease (2025) Vol. 6
Open Access
Development of a haemophilia A gene therapy shared decision‐making tool for clinicians
Jacqueline Limjoco, Courtney D. Thornburg
Haemophilia (2023) Vol. 29, Iss. 5, pp. 1184-1190
Open Access | Times Cited: 12
Gene Therapy for Hemophilia A: A Mixed Methods Study of Patient Preferences and Shared Decision-Making
Jacqueline Limjoco, Courtney D. Thornburg
Patient Preference and Adherence (2023) Vol. Volume 17, pp. 1093-1105
Open Access | Times Cited: 11
Deciphering conundrums of adeno-associated virus liver-directed gene therapy: focus on hemophilia
Glenn F. Pierce, Sylvia Fong, Brian Long, et al.
Journal of Thrombosis and Haemostasis (2023) Vol. 22, Iss. 5, pp. 1263-1289
Open Access | Times Cited: 10
Liver-related aspects of gene therapy for haemophilia: Call to action for collaboration between haematologists and hepatologists
Wolfgang Miesbach, Graham R. Foster, Flora Peyvandi
Journal of Hepatology (2022) Vol. 78, Iss. 3, pp. 467-470
Open Access | Times Cited: 16
How to translate and implement the current science of gene therapy into haemophilia care?
Cédric Hermans, Yves Gruel, Laurent Frenzel, et al.
Therapeutic Advances in Hematology (2023) Vol. 14, pp. 204062072211456-204062072211456
Open Access | Times Cited: 8
Gene Therapy in Hemophilia: A Transformational Patient Experience
Enayet Rasul, Ryan Hallock, Magnus Hellmann, et al.
Journal of Patient Experience (2023) Vol. 10
Open Access | Times Cited: 5
Access equity: key questions and challenges - A report from the 1st workshop of the European Haemophilia Consortium (EHC) Think Tank Workstream on Access Equity
Naja Skouw‐Rasmussen, Laura Savini
The Journal of Haemophilia Practice (2023) Vol. 10, Iss. 1, pp. 56-61
Open Access | Times Cited: 4
A 360-degree perspective on adeno-associated virus (AAV)-based gene therapy for haemophilia: Insights from the physician, the nurse and the patient
Wolfgang Miesbach, Greta Mulders, Daan Breederveld, et al.
Orphanet Journal of Rare Diseases (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Gene therapy for people with Haemophilia B: a proposed care delivery model in Italy
Giancarlo Castaman, Giovanni Di Minno, Paolo Simioni, et al.
Journal of Thrombosis and Haemostasis (2024) Vol. 22, Iss. 11, pp. 3084-3096
Open Access | Times Cited: 1
Development of the World Federation of Hemophilia Shared Decision‐Making Tool
Donna Coffin, Mark W. Skinner, Courtney D. Thornburg, et al.
Haemophilia (2024)
Closed Access | Times Cited: 1
The journey of gene therapy in haemophilia – putting the patient at the centre of the hub and spoke model
Declan Noone, Jan Astermark, Brian O’Mahony, et al.
The Journal of Haemophilia Practice (2022) Vol. 9, Iss. 1, pp. 156-166
Open Access | Times Cited: 7
Gentherapie der Hämophilie: Empfehlung der Gesellschaft für Thrombose- und Hämostaseforschung (GTH)
Wolfgang Miesbach, Johannes Oldenburg, Robert Klamroth, et al.
Hämostaseologie (2022) Vol. 43, Iss. 03, pp. 196-207
Open Access | Times Cited: 7
Awareness of individual goals, preferences, and priorities of persons with severe congenital haemophilia A for a tailored shared decision-making approach to liver-directed gene therapy. A practical guideline
Giovanni Di Minno, Gaia Spadarella, Nelson Mauro Maldonato, et al.
Blood Reviews (2023) Vol. 62, pp. 101118-101118
Closed Access | Times Cited: 3
Delivery of gene therapy in haemophilia treatment centres in the United States: Practical aspects of preparedness and implementation
Steven W. Pipe, Kayla Douglas, Nina Hwang, et al.
Haemophilia (2023) Vol. 29, Iss. 6, pp. 1430-1441
Open Access | Times Cited: 3
Shared decision-making for gene therapy in haemophilia care
Simon Fletcher, Kathryn Jenner, Kate Khair
The Journal of Haemophilia Practice (2023) Vol. 10, Iss. 1, pp. 62-67
Open Access | Times Cited: 3
Shared decision‐making related to treatment of haemophilia: A scoping review of influential factors and available support tools
Haowei Sun, Robert J. Klaassen, Dana L. Anger, et al.
Haemophilia (2024) Vol. 30, Iss. 4, pp. 880-893
Open Access
A multi-stakeholder collaborative approach to awareness, education and support needed in the haemophilia gene therapy patient journey – a report on insights from a European patient advisory board
Brian O’Mahony, Simon Fletcher, Manuel A. Baarslag, et al.
The Journal of Haemophilia Practice (2024) Vol. 11, Iss. 1, pp. 47-57
Closed Access
Mapping the Patient Experience in a Pediatric Hemophilia Unit: Our Patient Journey
Rubén Berrueco, Nuria Caballero, Mónica López-Tierling, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 20, pp. 6235-6235
Open Access
Gene therapy in hemophilia: the dawn of a new era
Roberta Gualtierotti, Andrea Giachi, Niccolò Bitto, et al.
Research and Practice in Thrombosis and Haemostasis (2024) Vol. 9, Iss. 1, pp. 102640-102640
Open Access
Page 1

Scroll to top